David McIntosh: UK Plasma Action – a Founder’s Reflections
David McIntosh, Founder and Chair of United Plasma Action, shared a post on LinkedIn:
”UK Plasma Action – a Founder’s Reflections
The UKPA campaign, launched in June 2019, was aimed at the discontinuation of a 23 year-old ban on the pharmaceutical use of UK donors’ plasma.
Much has happened since then and much good work has been done. Our donations are once again contributing to the manufacture of some vital plasma-derived medicines. The worst of the waste has been halted.
However, it seems appropriate, seven years on, to pause and reflect on the progress made so far – and the extent to which more action is still required.
The 20th Century fears about alleged risks of Variant Creutzfeldt Jakob disease in this context have now finally been dispelled.
However, the full Regulatory consequences and Healthcare gains from this welcome development are yet to be realised.
There is unfinished business here…….”

Other posts featuring David McIntosh on Hemostasis Today.
-
Nov 17, 2026, 01:27X. Long Zheng: Optimizing Treatment in Immune TTP
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C